Clinical Trial Update: Aprepitant to Mitigate Opioids' Cognitive Side Effects [NA]

View source ↗

Summary

Update on a clinical trial evaluating whether aprepitant can reduce cognitive dysfunction associated with opioid use. The current trial status is listed as unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Dysfunction

Drugs mentioned

• EMEND (aprepitant)

Snippet

Sponsor: University of Arizona | Conditions: Cognitive Dysfunction | NA | Status: UNKNOWN